logo
episode-header-image
Apr 2024
36m 59s

Money Talks: Why weight-loss drugs will ...

The Economist
About this episode

More than 1bn people around the world are obese. That means there should be extraordinary demand for drugs to cure or mitigate the condition. Novo Nordisk is now Europe’s most valuable company and Eli Lilly’s market value has more than doubled. Both make the “miracle” drugs that can help people shed up to a fifth of their body weight. But these drugs promise to do more than boost drug companies’ profits. How will they reshape the economy?


Hosts: Alice Fulwood, Mike Bird and Tom Lee-Devlin. Guests: The Economist’s Georgia Banjo; pharmaceuticals analyst Michael Nedelcovych; and John Cawley, a professor of public policy and economics at Cornell University.


Subscribers to Economist Podcasts+ can listen to our January 2023 episode on the economics of thinness.


Sign up for our new weekly newsletter dissecting the big themes in markets, business and the economy at www.economist.com/moneytalks 


Listen to what matters most, from global politics and business to science and technology—subscribe to Economist Podcasts+


For more information about how to access Economist Podcasts+, please visit our FAQs page or watch our video explaining how to link your account.


Hosted on Acast. See acast.com/privacy for more information.

Up next
Today
Sprawl of duty: Trump’s tariff drama
Once again President Donald Trump extended the deadline for spine-stiffening tariffs to go into effect on trading partners. We look at the effects of all the uncertainty. Brazil once dominated the world of football; we ask where it went wrong and assess the route to a comeback. A ... Show More
21m 53s
Yesterday
The French reconnection: Macron in Britain
Anglo-French relations have not been so good since before the Brexit vote. Beneath the state-visit pageantry, though, there is much co-operation for President Emmanuel Macron and Prime Minister Keir Starmer to discuss. Gangs have infiltrated many of Latin America’s mining operati ... Show More
21m 10s
Jul 7
Trump card: can he broker a Gaza deal?
While Israel and Hamas officials discuss a ceasefire via mediators in Qatar, a key meeting will take place at the White House today, when Israel’s prime minister talks to the US president. Why the Chinese Communist Party is removing alcohol from official events. And remembering J ... Show More
21m 7s
Recommended Episodes
Sep 2023
Money Talks: The price of cheaper medicines
One of the many aims of President Joe Biden’s signature legislation, the Inflation Reduction Act, is to cut the cost of drugs prescribed by Medicare, a government health insurance programme for Americans 65 and over. But the policy could have some side-effects for patients far be ... Show More
44m 53s
Dec 2021
Money Talks: The not-so-great resignation
The idea that the pandemic has prompted people to quit their jobs en masse fills corporate earnings calls, headlines and social media. But do the data hold up? Host Patrick Lane investigates what is really going on in the labour market. Will the Biden administration usher in a ne ... Show More
28m 37s
May 2024
Swat off the press: Meta v Canada’s news ploy
A bid to squeeze money from social-media platforms that link to news content has backfired: what was intended to help publishers is instead harming them. America’s workers still work more than Europe’s; what is changing is where they do it (9:44). And remembering Shirley Conran, ... Show More
23m 40s
Feb 2022
Money Talks: The next financial crisis
Over the past 15 years power and risk in financial markets have shifted radically. New investors have flooded in and, buoyed by pandemic stimulus, most have had an incredible ride. But as policymakers put the brakes on, global financial markets are starting to wobble. How might t ... Show More
39m 49s
Mar 2024
The Intelligence: Fed reckoning
America’s central bank left rates untouched, to widespread market delight. Why is this economic cycle confounding expectations so much, and how to bring it to a gentle end? We look at the modern fortunes of Vodafone, a once-mighty telecoms firm that is slimming down to get health ... Show More
21m 28s
Sep 2021
Money Talks: Opening gambit at Intel
The notoriously insular American chipmaker wants to throw open the doors. Succeed or fail, this reversal will shake up a $600bn industry at the heart of the global economy. Plus, Harvard economist Edward Glaeser explains how the pandemic is transforming the world’s cities. And, a ... Show More
23m 35s
Mar 2024
The Intelligence: Europe is not so hot on its green parties
Melting ski slopes, floods and droughts are enraging the continent’s citizens, but not quite enough for them to consider voting differently. Our correspondent explains what the electorate is weighing up. The world’s largest maker of glasses is branching out into tech (10:41). And ... Show More
24m 14s
Mar 2024
The Intelligence: Drug gateway
A visit to a port of entry at America’s Mexican border reveals the difficulties in stopping the flood of fentanyl—a cheap, potent and ever more deadly drug. Javier Milei, Argentina’s president, is looking to blunt measures to escape an economic morass; our correspondent says he s ... Show More
25m 25s
Oct 2023
So the Tory goes: Britain’s Conservatives meet
Divisions within the ruling party are on full display this week, and the provocative policies Prime Minister Rishi Sunak announced are unlikely to help the Conservatives’ woeful polling numbers. Early results suggest that new drugs initially prescribed for weight loss may be a po ... Show More
24m 57s
May 2024
Stores of value: regulators lean on app vendors
Apple and Alphabet operate what is in effect a smartphone-app duopoly. Governments want to curb their power, but it is not clear whether more competition would change things. We ask why India’s election is so eye-wateringly expensive; the country’s size is not the only answer (08 ... Show More
20m 11s